#69 - Anne Wojcicki of 23andMe and Sam Altman

In this episode of the Y Combinator podcast, Anne Wojcicki, CEO of 23andMe, shares her insights on the company's journey, the hurdles it faced, and its vision for the future. She recounts her transition from Wall Street to revolutionizing healthcare through direct-to-consumer genetic testing, emphasizing the initial pushback from the medical community. Wojcicki stresses the importance of staying committed to a long-term vision and the need to hire the right talent. Looking forward, she sees 23andMe leveraging its extensive genetic database to foster personalized health breakthroughs, ultimately helping people lead healthier, longer lives.